Summary:
RSVP Study: A Clinical Study Evaluating a Mechanism of Action for Stable Vitiligo
Vitiligo is a disease affecting approximately 6.5 million people in the U.S. resulting in loss of color, or pigmentation, in patches of skin that impacts the quality of life for those living with the condition.
Clinical studies are underway exploring the use of RECELL for the repigmentation of stable vitiligo.
Why is the RSVP Study being done?
The RSVP Study is evaluating the application of Spray-On SkinTM Cells, prepared using the investigational RECELL Device, for safe and effective repigmentation of stable vitiligo.
Is the RSVP Study an option for you?
You may be able to participate in the RSVP Study if all of the following criteria are met:
- You are 18 years of age or older.
- You have stable vitiligo (not changing in size).
- You can provide photos of your vitiligo that were taken within the past 12 months (photographs can be from you or from your doctor).
There are other eligibility requirements that the study doctor will review with you.